Tranexamic acid in pediatric trauma: why not?

被引:39
作者
Beno, Suzanne [1 ]
Ackery, Alun D. [2 ]
Callum, Jeannie [3 ]
Rizoli, Sandro [2 ]
机构
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[3] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
来源
CRITICAL CARE | 2014年 / 18卷 / 04期
关键词
ANTIFIBRINOLYTIC DRUGS; INDEPENDENT PREDICTOR; CARDIAC-SURGERY; BRAIN-INJURY; COAGULOPATHY; CHILDREN; MORTALITY; TRANSFUSION; ADMISSION; EFFICACY;
D O I
10.1186/cc13965
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Trauma is a leading cause of death in pediatrics. Currently, no medical treatment exists to reduce mortality in the setting of pediatric trauma; however, this evidence does exist in adults. Bleeding and coagulopathy after trauma increases mortality in both adults and children. Clinical research has demonstrated a reduction in mortality with early use of tranexamic acid in adult trauma patients in both civilian and military settings. Tranexamic acid used in the perioperative setting safely reduces transfusion requirements in children. This article compares the hematologic response to trauma between children and adults, and explores the potential use of tranexamic acid in pediatric hemorrhagic trauma.
引用
收藏
页数:5
相关论文
共 40 条
  • [1] Albiani DA, 2008, CAN J OPHTHALMOL, V43, P428, DOI [10.3129/i08-066, 10.1139/i08-066]
  • [2] [Anonymous], 2013, Prescrire Int, V22, P189
  • [3] A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use
    Basta, Marten N.
    Stricker, Paul A.
    Taylor, Jesse A.
    [J]. PEDIATRIC SURGERY INTERNATIONAL, 2012, 28 (11) : 1059 - 1069
  • [4] CRASH-3-tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial
    Dewan, Yashbir
    Komolafe, Edward O.
    Mejia-Mantilla, Jorge H.
    Perel, Pablo
    Roberts, Ian
    Shakur, Haleema
    [J]. TRIALS, 2012, 13
  • [5] Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel
    Dzik, Walter H.
    Blajchman, Morris A.
    Fergusson, Dean
    Hameed, Morad
    Henry, Blair
    Kirkpatrick, Andrew W.
    Korogyi, Teresa
    Logsetty, Sarvesh
    Skeate, Robert C.
    Stanworth, Simon
    MacAdams, Charles
    Muirhead, Brian
    [J]. CRITICAL CARE, 2011, 15 (06)
  • [6] The Efficacy of Antifibrinolytic Drugs in Children Undergoing Noncardiac Surgery: A Systematic Review of the Literature
    Faraoni, David
    Goobie, Susan M.
    [J]. ANESTHESIA AND ANALGESIA, 2014, 118 (03) : 628 - 636
  • [7] Systematic review: tranexamic acid for upper gastrointestinal bleeding
    Gluud, L. L.
    Klingenberg, S. L.
    Langholz, S. E.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (09) : 752 - 758
  • [8] A Practical Tranexamic Acid Dosing Scheme Based on Population Pharmacokinetics in Children Undergoing Cardiac Surgery
    Grassin-Delyle, Stanislas
    Couturier, Roland
    Abe, Emuri
    Alvarez, Jean Claude
    Devillier, Philippe
    Urien, Saik
    [J]. ANESTHESIOLOGY, 2013, 118 (04) : 853 - 862
  • [9] Cost-Effectiveness Analysis of Administering Tranexamic Acid to Bleeding Trauma Patients Using Evidence from the CRASH-2 Trial
    Guerriero, Carla
    Cairns, John
    Perel, Pablo
    Shakur, Haleema
    Roberts, Ian
    [J]. PLOS ONE, 2011, 6 (05):
  • [10] Harvey V, 2013, ANN EMERG MED